Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

ABSTRACT Aim: The Physician's Routine Evaluation of Safety and Efficacy of NovoMix* 30 Therapy (PRESENT) aims to assess the safety and efficacy of biphasic insulin aspart (BIAsp30) used in routine clinical practice. Methods: This was a large, multi-national, multi-centre, prospective, 6-month s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2007-12, Vol.23 (12), p.3209-3214
Hauptverfasser:	Shestakova, M., Sharma, S. K., Almustafa, M., Min, K. W., Ayad, N., Azar, S. T., Danciulescu, R., Khutsoane, D., Guler, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biphasic human insulin Biphasic insulin aspart 30 Biphasic Insulins Blood Glucose - analysis Blood Glucose - drug effects Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female HbA1c Humans Hyperglycemia - drug therapy Hyperglycemia - etiology Hypoglycaemia Hypoglycemic Agents - therapeutic use Insulin - analogs & derivatives Insulin - analysis Insulin - pharmacology Insulin - therapeutic use Insulin Aspart Insulin, Isophane Male Middle Aged Treatment Outcome Type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	ABSTRACT Aim: The Physician's Routine Evaluation of Safety and Efficacy of NovoMix* 30 Therapy (PRESENT) aims to assess the safety and efficacy of biphasic insulin aspart (BIAsp30) used in routine clinical practice. Methods: This was a large, multi-national, multi-centre, prospective, 6-month study in type 2 diabetes mellitus patients who were prescribed BIAsp30. Efficacy endpoints included changes in HbA1c, fasting plasma glucose (FPG), postprandial plasma glucose (PPPG), and proportion who achieved target HbA1c
ISSN:	0300-7995 1473-4877
DOI:	10.1185/030079907X253636